KOC
SRTA

Koss-Olinger Consulting’s Strata Critical Medical Inc SRTA Stock Holding History

Koss-Olinger Consulting’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-40,000
Closed -$420K – 241
2021
Q2 		$420K Hold
40,000
– – 0.06% 153
2021
Q1 		$412K Buy
+40,000
New +$556K 0.07% 147

Other funds holding SRTA

HVCM
HG Vora Capital Management New York $191M AUM 1.23% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
RA
RiverPark Advisors New York $276M AUM 15.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DRS
Deane Retirement Strategies New Orleans, Louisiana $236M AUM 22.39% 1-Year Est. Return

Koss-Olinger Consulting's SRTA Position: Q3 2021 in Review

Koss-Olinger Consulting sold out of Strata Critical Medical Inc (SRTA) in Q3 2021, closing a stake of 40,000 shares — an estimated $420K sold.

Koss-Olinger Consulting first reported a position in SRTA in Q1 2021 and held it in 2 quarters. The position peaked at $420K in Q2 2021. 81 funds tracked by Wall St. Rank hold SRTA as of Q3 2021.

  • Koss-Olinger Consulting reported no remaining Strata Critical Medical Inc position as of Q3 2021 after selling out during the quarter.
  • Koss-Olinger Consulting sold 40,000 Strata Critical Medical Inc shares in Q3 2021, an estimated $420K.
  • Koss-Olinger Consulting first reported a position in Strata Critical Medical Inc in Q1 2021 and held it in 2 quarters.
  • Koss-Olinger Consulting's Strata Critical Medical Inc position peaked at $420K in Q2 2021.
  • 81 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2021.

Based on Koss-Olinger Consulting's 13F filing for Q3 2021, filed 9 Nov 2021.